Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study
Clinical trial NCT07440537 · RECRUITING
Trial details
- NCT number
- NCT07440537
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-27
- Primary completion
- 2027-03-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.